Broadfin Capital, LLC current holdings: USA Other Stocks
Broadfin Capital, LLC reported $0.79 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 52 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are HORIZON PHARMA PLC, RETROPHIN INC, NOVADAQ TECHNOLOGIES INC.
- HORIZON PHARMA PLC: Country of operation —; Class SHS; Shares 5,503,182; Value $99,773,000.
- RETROPHIN INC: Country of operation —; Class COM; Shares 3,469,271; Value $77,642,000.
- NOVADAQ TECHNOLOGIES INC: Country of operation —; Class COM; Shares 5,174,209; Value $59,866,000.
- PROGENICS PHARMACEUTICALS IN: Country of operation —; Class COM; Shares 8,951,169; Value $56,661,000.
Form 13F-HR as filed (SEC CIK 1511901): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
HORIZON PHARMA PLC
CUSIP G4617B105 | | SHS | 5,503,182 | $99,773,000 | 2016-09-30 | 2016-11-14 |
|---|
RETROPHIN INC
CUSIP 761299106 | | COM | 3,469,271 | $77,642,000 | 2016-09-30 | 2016-11-14 |
|---|
NOVADAQ TECHNOLOGIES INC
CUSIP 66987G102 | | COM | 5,174,209 | $59,866,000 | 2016-09-30 | 2016-11-14 |
|---|
PROGENICS PHARMACEUTICALS IN
CUSIP 743187106 | | COM | 8,951,169 | $56,661,000 | 2016-09-30 | 2016-11-14 |
|---|
LA JOLLA PHARMACEUTICAL CO
CUSIP 503459604 | | COM PAR $.0001 2 | 1,447,053 | $34,425,000 | 2016-09-30 | 2016-11-14 |
|---|
ENDO INTL PLC
CUSIP G30401106 | | SHS | 1,454,538 | $29,309,000 | 2016-09-30 | 2016-11-14 |
|---|
ARATANA THERAPEUTICS INC
CUSIP 03874P101 | | COM | 3,085,979 | $28,885,000 | 2016-09-30 | 2016-11-14 |
|---|
ANTARES PHARMA INC
CUSIP 036642106 | | COM | 14,885,393 | $25,007,000 | 2016-09-30 | 2016-11-14 |
|---|
LION BIOTECHNOLOGIES INC
CUSIP 53619R102 | | COM | 2,638,259 | $21,713,000 | 2016-09-30 | 2016-11-14 |
|---|
RECRO PHARMA INC
CUSIP 75629F109 | | COM | 2,450,086 | $21,659,000 | 2016-09-30 | 2016-11-14 |
|---|
OPHTHOTECH CORP
CUSIP 683745103 | | COM | 410,000 | $18,913,000 | 2016-09-30 | 2016-11-14 |
|---|
MEDGENICS INC
CUSIP 58436Q203 | | COM NEW | 3,370,306 | $18,773,000 | 2016-09-30 | 2016-11-14 |
|---|
TELIGENT INC NEW
CUSIP 87960W104 | | COM | 2,201,901 | $16,734,000 | 2016-09-30 | 2016-11-14 |
|---|
ADVAXIS INC
CUSIP 007624208 | | COM NEW | 1,564,679 | $16,726,000 | 2016-09-30 | 2016-11-14 |
|---|
IGNYTA INC
CUSIP 451731103 | | COM | 2,256,546 | $14,194,000 | 2016-09-30 | 2016-11-14 |
|---|
BIODELIVERY SCIENCES INTL IN
CUSIP 09060J106 | | COM | 5,188,794 | $14,010,000 | 2016-09-30 | 2016-11-14 |
|---|
AEGERION PHARMACEUTICALS INC
CUSIP 00767E102 | | COM | 4,361,291 | $12,953,000 | 2016-09-30 | 2016-11-14 |
|---|
ACORDA THERAPEUTICS INC
CUSIP 00484M106 | | COM | 604,700 | $12,626,000 | 2016-09-30 | 2016-11-14 |
|---|
DERMA SCIENCES INC
CUSIP 249827502 | | COM PAR $.01 | 2,562,104 | $11,965,000 | 2016-09-30 | 2016-11-14 |
|---|
SEASPINE HLDGS CORP
CUSIP 81255T108 | | COM | 1,100,007 | $11,121,000 | 2016-09-30 | 2016-11-14 |
|---|
QLT INC
CUSIP 746927102 | | COM | 5,269,831 | $10,856,000 | 2016-09-30 | 2016-11-14 |
|---|
CORIUM INTERNATIONAL ORD
CUSIP 21887L107 | | COM | 1,919,721 | $10,808,000 | 2016-09-30 | 2016-11-14 |
|---|
ENDOLOGIX INC
CUSIP 29266S106 | | COM | 800,000 | $10,240,000 | 2016-09-30 | 2016-11-14 |
|---|
PARATEK PHARMACEUTICALS INC
CUSIP 699374302 | United States | COM | 786,134 | $10,228,000 | 2016-09-30 | 2016-11-14 |
|---|
INTERSECT ENT INC
CUSIP 46071F103 | | COM | 638,600 | $10,115,000 | 2016-09-30 | 2016-11-14 |
|---|
ZOGENIX INC
CUSIP 98978L204 | | COM NEW | 882,312 | $10,085,000 | 2016-09-30 | 2016-11-14 |
|---|
MEDICINES CO
CUSIP 584688105 | | COM | 255,600 | $9,646,000 | 2016-09-30 | 2016-11-14 |
|---|
DEPOMED INC
CUSIP 249908104 | | COM | 379,474 | $9,475,000 | 2016-09-30 | 2016-11-14 |
|---|
DURECT CORP
CUSIP 266605104 | | COM | 6,395,206 | $8,889,000 | 2016-09-30 | 2016-11-14 |
|---|
STRONGBRIDGE BIOPHARMA PLC
CUSIP G85347105 | | SHS USD | 1,656,706 | $8,648,000 | 2016-09-30 | 2016-11-14 |
|---|
EGALET CORP
CUSIP 28226B104 | | COM | 1,134,750 | $8,635,000 | 2016-09-30 | 2016-11-14 |
|---|
AVIRAGEN THERAPEUTICS INC
CUSIP 053761102 | | COM | 3,486,711 | $6,694,000 | 2016-09-30 | 2016-11-14 |
|---|
MIRATI THERAPEUTICS INC
CUSIP 60468T105 | United States | COM | 1,000,000 | $6,610,000 | 2016-09-30 | 2016-11-14 |
|---|
IDERA PHARMACEUTICALS INC
CUSIP 45168K306 | | COM NEW | 2,427,745 | $6,215,000 | 2016-09-30 | 2016-11-14 |
|---|
RAPTOR PHARMACEUTICAL CORP
CUSIP 75382F106 | | COM | 664,800 | $5,963,000 | 2016-09-30 | 2016-11-14 |
|---|
SCYNEXIS INC
CUSIP 811292101 | | COM | 1,477,273 | $5,717,000 | 2016-09-30 | 2016-11-14 |
|---|
CARDIOVASCULAR SYS INC DEL
CUSIP 141619106 | | COM | 230,532 | $5,473,000 | 2016-09-30 | 2016-11-14 |
|---|
NEVRO CORP
CUSIP 64157F103 | United States | COM | 50,555 | $5,277,000 | 2016-09-30 | 2016-11-14 |
|---|
ALCOBRA LTD
CUSIP M2239P109 | | SHS | 2,047,449 | $5,057,000 | 2016-09-30 | 2016-11-14 |
|---|
TENAX THERAPEUTICS INC
CUSIP 88032L100 | | COM | 1,968,631 | $4,557,000 | 2016-09-30 | 2016-11-14 |
|---|
NEXVET BIOPHARMA PUB LTD CO
CUSIP G6503X109 | | ORD SHS | 1,017,255 | $4,222,000 | 2016-09-30 | 2016-11-14 |
|---|
MEDIWOUND LTD
CUSIP M68830104 | | ORD SHS | 530,985 | $4,089,000 | 2016-09-30 | 2016-11-14 |
|---|
ANTHERA PHARMACEUTICALS INC
CUSIP 03674U201 | | COM NEW | 1,154,674 | $3,637,000 | 2016-09-30 | 2016-11-14 |
|---|
CONTRAFECT CORP
CUSIP 212326102 | | COM | 1,429,109 | $3,544,000 | 2016-09-30 | 2016-11-14 |
|---|
TREVENA INC
CUSIP 89532E109 | | COM | 492,000 | $3,321,000 | 2016-09-30 | 2016-11-14 |
|---|
TANDEM DIABETES CARE INC
CUSIP 875372104 | | COM | 334,300 | $2,561,000 | 2016-09-30 | 2016-11-14 |
|---|
WINDTREE THERAPEUTICS INC
CUSIP 97382D105 | | COM | 777,797 | $1,991,000 | 2016-09-30 | 2016-11-14 |
|---|
CIDARA THERAPEUTICS INC
CUSIP 171757107 | | COM | 166,875 | $1,911,000 | 2016-09-30 | 2016-11-14 |
|---|
DEXTERA SURGICAL INC
CUSIP 252366109 | | COM | 844,167 | $1,587,000 | 2016-09-30 | 2016-11-14 |
|---|
CAS MED SYS INC
CUSIP 124769209 | | COM PAR $0.004 | 562,030 | $972,000 | 2016-09-30 | 2016-11-14 |
|---|
RXI PHARMACEUTICALS CORP NEW
CUSIP 74979C501 | | COM | 316,010 | $585,000 | 2016-09-30 | 2016-11-14 |
|---|
STRATA SKIN SCIENCES INC
CUSIP 86272A107 | | COM | 961,422 | $510,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |